The civic record
Read. Follow. Verify.Maryland limits Health Services Cost Review Commission member holdover terms to six months
Last action · April 13, 2026: Third Reading Passed (132-0)Sponsor: Pam Beidle
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Would Do
Authorizing a member of the Health Services Cost Review Commission to continue to serve for a period not to exceed 6 months after the expiration of the member's term of office, rather than until a successor is appointed and qualifies; and repealing the authority of a member of the Commission who was appointed after a term began to serve until a successor is appointed and qualifies.
Changes the length of time outgoing members can remain on a state health regulatory board, taking effect October 1, 2026.
Who It Would Affect
Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.
Health Services Cost Review Commission members
Members are restricted to a maximum 6-month holdover period after their term expires instead of serving indefinitely until a successor qualifies.
Governor
The Governor faces a fixed 6-month window to appoint successors to Commission members whose terms have expired.
Key Facts
- Members of the Health Services Cost Review Commission are permitted to continue serving for a period not to exceed 6 months after the expiration of their term.
- The authority of a member appointed after a term has begun to serve until a successor is appointed and qualifies is repealed.
- The Commission consists of seven members appointed by the Governor with the advice and consent of the Senate.
- The Act takes effect October 1, 2026.
Frequently Asked Questions
How long can a member of the Health Services Cost Review Commission continue to serve after their term expires?
When does this change take effect?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Currently passed both. The next step in the legislative lifecycle is Law.
Procedural history
12 actions- Apr 13, 2026HouseFloorThird Reading Passed (132-0)
- Apr 13, 2026HouseFloorSecond Reading Passed with Amendments
- Apr 13, 2026HouseFavorable with Amendments { 593027/1 Adopted
- Apr 11, 2026HouseCommitteeFavorable with Amendments Report by Health
- Apr 9, 2026HouseCommitteeRereferred to Health
- Apr 8, 2026HouseCommitteeReferred Rules and Executive Nominations
Show 6 earlier actions
- Apr 8, 2026SenateFloorThird Reading Passed (43-0)
- Apr 7, 2026SenateFloorSecond Reading Passed
- Apr 7, 2026SenateFloorFavorable Adopted
- Apr 6, 2026SenateCommitteeFavorable Report by Finance
- Jan 19, 2026SenateHearing 1/27 at 2:30 p.m.
- Jan 16, 2026SenateIntroducedFirst Reading Finance
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Connected Entities
Sources
mgaleg.maryland.gov
Analysis Score
0–100- Significance35How much this matters to a regular citizen
- Controversy5Intensity of disagreement among stakeholders
- Entertainment2Compellingness for a non-policy-wonk reader
- Buzz10Current news / social attention level
Publisher tools